and cash flow, we ended the 2nd quarter with $439,700,000 in cash and cash equivalents and $7,000,000,000 of gross debt. SS and C's net debt, which excludes cash and cash equivalents of 114,400,000 held at DemaniRx was $6,600,000,000 as of June 30. Operating cash flow for the 6 months was $584,200,000 $136,700,000 or a $30,500,000 increase compared to the same period in 2022. And for the 6 months ended June 30, we purchased Treasury stock for a total of $246,600,000 or 4,300,000 shares at an average price of $57.78 We declared and paid a dividend of $101,000,000 common stock compared to 102,000,000 last year. Net debt payments for the 6 months was 169,800,000 And for the 6 months, we paid $226,900,000 of interest compared to $112,600,000 in 2022.